Black Canadians Face Major Prescription Drug Access Disparities
A recent study published in CMAJ Open highlights alarming disparities in prescription drug coverage and medication adherence among Canadian Black adults, underscoring significant health equity gaps. Utilizing data from the 2019 Canadian Health Measures Survey, researchers found that only 57.5% of Black adults possess private prescription drug coverage, a stark contrast to 73.1% of non-Black adults – a 15.6 percentage point difference. This critical lack of coverage directly translates into financial barriers, making Black adults 1.8 times more likely to report skipping essential medications due to cost.
These findings reveal a systemic issue where the “risk” of inadequate healthcare access disproportionately affects Black communities. Forgoing necessary prescriptions can lead to severe health consequences, including worsening chronic conditions, increased disease progression, and potentially higher long-term healthcare utilization, such as emergency room visits and hospitalizations. The study emphasizes that these disparities are not isolated but are deeply rooted in broader socioeconomic factors, employment inequities, and systemic racism that limit access to jobs offering comprehensive health benefits.
The problem is particularly acute among lower-income Black adults (earning less than $50,000 annually), where only 45.4% have private coverage compared to 69.1% of their non-Black counterparts in the same income bracket. Similar gaps exist for Black adults who are unemployed, not in the labor force, or self-employed. Addressing these inequities would yield substantial “benefits,” primarily by improving health outcomes for a vulnerable population, reducing financial strain, and fostering greater health equity across Canada.
The research team, led by Dr. Fawaad Iqbal, strongly advocates for robust policy interventions to rectify these imbalances. They specifically point to the implementation of a universal, equitable Pharmacare program as a vital solution. Such a program could mitigate the financial burden of prescription medications, ensuring that access to essential drugs is based on medical need rather than socioeconomic status, thereby closing critical gaps in Canada’s healthcare system.
